Aaron Kantoff - Jun 17, 2025 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Jun 17, 2025
Transactions value $
$0
Form type
4
Date filed
6/18/2025, 04:25 PM
Previous filing
Jun 6, 2025
Next filing
Sep 9, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KANTOFF AARON Director C/O AVALO THERAPEUTICS, INC., 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE /s/ Donald R. Reynolds, by Power of Attorney 2025-06-18 0001862734

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +20.1K $0.00 20.1K Jun 17, 2025 Common Stock 20.1K $4.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date.